On October 20, the Cardiac Rehabilitation Center of Anning First People's Hospital was certified by the first batch of "National Standardized In vitro Counter-Repellent Center" of the In vitro Counter-Repellent Branch of the China Society of Biomedical Engineering, becoming the f

2025/06/1704:13:35 regimen 1409

On October 20, the Cardiac Rehabilitation Center of Anning First People's Hospital obtained the first batch of "National Standardized In vitro Counter-Pulse Branch of the Chinese Society of Biomedical Engineering, becoming the first institution in Yunnan Province and one of the 50 in the country to obtain certification.

What is in vitro counter-pulsation?

In vitro counter-pumping (EECP) is a non-invasive auxiliary circulation technology for the treatment of ischemic diseases. It avoids the side effects of traditional treatments or drugs. It does not require the patient to be hospitalized and can be completed in the outpatient clinic. It safely promotes accelerated blood flow in the blood vessels in a relaxed and comfortable manner, significantly alleviates chest tightness , chest pain , and precordial discomfort, improves the quality of life of patients with coronary heart disease , and is known as "a heart bypass without surgery."

The principle of in vitro counterpulsation?

uses the human electrocardiogram wave as the trigger signal. During the diastolic period, the pressure of airbag is used to rush the air from the distal end of the limb to the proximal end (calves, thighs, buttocks) to sequentially so that blood in the lower body of the body is perfused into the upper body, thereby increasing the blood flow of important organs (heart, brain, kidneys, etc.) and improving the symptoms of insufficient blood supply to the coronary artery. Before the heart contraction period, the airbag quickly exhausts, the compressed limb blood vessels suddenly relax, and the external force decreases, which is conducive to the blood ejected from the ventricle flowing into the limb artery through the aorta. By increasing the aortic diastolic pressure to increase the blood supply of coronary , the ischemic myocardium is rescued, and the heart's blood pumping function is improved.

Which diseases can be treated with new in vitro counterpulsive system?

1. Cardiovascular disease: stable and unstable angina pectoris , acute myocardial infarction recovery stage, coronary artery bypass surgery, coronary heart disease and ischemic heart failure, after percutaneous intraluminal arterioplasty (PTCA);

2. Cerebrovascular disease: cerebral atherosclerosis, transient cerebral ischemia , vascular brain dementia, vertebra-based Insufficient blood supply of the base artery (including vertebral artery cervical spondylosis ), ischemic stroke;

III. Rehabilitation treatment: treatment for sudden deafness in the elderly, severe insomnia, cardiovascular and ischemic diseases recovery period, diabetes and ischemic eye disease and kidney disease treatment, improvement of liver disease microcirculation and treatment of stubborn constipation, rehabilitation treatment for pediatric cerebral palsy, improvement of systemic microcirculation is suitable for sub-healthy people such as "three highs" lack of exercise obesity, rehabilitation treatment for bones, joints and muscles, and rehabilitation treatment for male sexual dysfunction.